75N94024Q00154.Combined Synopsis Solicitation.pdf

COMBINED SYNOPSIS / SOLICITATION WORKFORM

(1) Action Code: Combined Synopsis/Solicitation

(2) Date: 7/1/2024

(3) Year: 2024

(4) Contracting Office Zip Code: 20892

(5) Project Service Code: 6650 - OPTICAL INSTRUMENTS, TEST EQUIPMENT, COMPONENTS

AND ACCESSORIES

(6)

(7) Contracting Office Address:

6710B Rockledge Drive Bethesda, MD 20892

(8) Subject/Title: Acquisition of MLD Victor Nivo Alpha Instrument

(9) Proposed Solicitation Number: 75N94024Q00154

(10) Closing Response Date: 7/17/2024

(11) Contact Point: Amber Harris

(12) Contract Award and Solicitation Number: TBD

(13) Contract Award Dollar Amount: TBD

(14) Contract Line Item Number(s): TBD

(15) Contractor Award Date: TBD

(16) Contractor Name: TBD

(17) Description: (Background)

(i) “This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued.”

(ii) The solicitation number is 75N94024Q00154 and the solicitation is issued as a request for quote (RFQ).

(iii) The solicitation document, the incorporated provisions and clauses are those in effect through FAC 2024-05 Effective May 22, 2024.

(iv) The associated NAICS code is 334516, Analytical Laboratory Instrument Manufacturing, and the small business size standard is 1,000. The acquisition is being conducted in accordance with the procedures of FAR Part 12 and FAR Part 13.

(v) The Contractor Requirements are listed below:

1.0 PURCHASE ORDER TITLE

Acquisition of MLD Victor Nivo Alpha Instrument

2.0 BACKGROUND

The mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is to conduct and support medical research and research training and to disseminate science-based information on diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases, to improve people’s health and quality of life.

The NIDDK supports a wide range of medical research through grants to universities and other medical research institutions across the country. The Institute also supports government scientists who conduct basic, translational, and clinical research across a broad spectrum of research topics and serious, chronic diseases and conditions related to the Institute's mission. In addition, the NIDDK supports research training for students and scientists at various stages of their careers and a range of education and outreach programs to bring science-based information to patients and their families, health care professionals, and the public.

The Molecular Recognition Section (MRS) of the Laboratory of Bioorganic Chemistry Designs, chemically synthesizes, and characterizes pharmacologically new agonists and antagonists for the four subtypes of adenosine receptors (ARs) and eight subtypes of P2Y receptors and to explore their potential for treating human disease conditions.

Interests in the structure and pharmacology of receptors and in developing drugs that act as agonists or antagonists of G protein-coupled receptors (GPCRs). The focus is on receptors for purines, encompassing both adenosine receptors and P2 receptors, which are activated by ATP, UTP and other extracellular nucleotides.

3.0 OBJECTIVE

The objective is to replace a failed and no longer supported unit – MLD Victor Nivo Alpha Instrument by Perkin Elmer, the formally named manufacture. The measurement of cellular cAMP is a requirement for previous and ongoing research. The results must match previous experiments, so we request that we use the same manufacture (Perkin Elmer is now Revvity Health Sciences, Inc).

4.0 SALIENT / REQUIRED FEATURES AND SPECIFICATIONS

The following measurement of cellular cAMP is a requirement for these studies. as outlined in these recent publications:

Gao, Z.G., Levitan, I.M., Inoue, A., Wei, Q., Jacobson, K.A. A2B adenosine receptor activation and modulation by protein kinase C, iScience, 2023, 26:107178, doi:

10.1016/j.isci.2023.107178. PMC10316653

Shiriaeva, A., Park, D.J., Kim, G., Lee, Y., Hou, X., Jarhad, D.B., Kim, G., Yu, J., Hyun, Y.E., Kim, W., Gao, Z.G., Jacobson, K.A., Han, G.W., Stevens, R.C., Jeong, L.S., Choi, S., Cherezov, V. GPCR agonist-to-antagonist conversion: Enabling the design of nucleoside functional switches for the A2A adenosine receptor. J. Med. Chem., 2022, 65(8):6325–6337, PMC9469204

Puhl, A.C., Gao, Z.G., Jacobson, K.A., Ekins S. Machine learning for discovery of new ADORA modulators. Front. Pharmacol. 2022, 13:920643. doi:

10.3389/fphar.2022.920643. PMC9257522

VICTOR Nivo alpha F Multimode Plate Reader with 4 detection technologies and standard features are the following:

- Filter-based Absorbance including 405/10nm filter

- Luminescence detection technology including 700nm IR cut-off filter

- Fluorescence intensity detection including FITC filters (480/30nm for excitation and 530/30nm for emission) and 50/50 dichroic beam splitter

- Laser-based Alpha Technology including D660A Dichroic mirror and 575/110nm emission filter for all single-channel Alpha assays

- Top (>&)> Bottom microplate-plate detection for all technologies

- Temperature control: 3°C above ambient up to 65°C

- Shaker with three modes: linear, orbital and double orbital

- 1 ‒ 1536-well plate reading capability

- Wi-Fi modem and Ethernet network cable for remote control

- Device control software with data analysis

- Compact and light-weight design to fit on every bench

- Dynamic filter wheel with 32 filter storage positions

- Operation-system independent control software to enable access with Android, Mac, Windows computers and tablets

- Ready for gas control upgrade - Ready for Technology upgrade to add TRF capability (DELFIA, LANCE, HTRF) and Fluorescence Polarization

- Ready for dispenser upgrade

- Power Cords included: Installation kits for different regions available

- Dimensions: Width 20 cm, Depth 50 cm, Height 27 cm

VICTOR Nivo Test Plate Kit

-Optional test plate for system checks and to test reader functionalities for all detection modes (except FP).

- tests plate carrier alignment

- pre-written test routines for ABS, FI, TRF, LUM

- Status LED

- Power Cords included:-

- Dimensions: - Product Weight: 0.5 kg

- Installation: Not Required.

Task Areas:

Task Area 1 – Delivery/Installation Shipping Instructions: The National Institutes of Health, NIDDK, Bldg. 8 Center Drive, Room B1A23, Bethesda, MD 20814.

Delivery/Installation: The Contractor shall provide delivery no later than August, 1, 2024.

Warranty: The Contractor shall provide a one-year warranty on the equipment (parts, labor and travel).

Task Area 2 – Training The Contractor shall provide training upon installation of equipment.

5.0 PURCHASE ORDER TYPE

This Purchase Order is to be a Firm-Fixed Price.

6.0 PERIOD OF PERFORMANCE AND PAYMENT BREAKDOWN

Period of Performance: Delivery by 8/1/2024

Payment shall be made in one lump sum. Payment terms per the vendor allowance being a large business.

7.0 INSPECTION AND ACCEPTANCE

The Project Officer or the Project Officer Supervisor will perform inspection and acceptance of materials and services to be provided. For equipment orders, inspection and acceptance will be done AFTER All materials are unpacked, installed, and test run for operation. Receiving will be completed no later than 7 days following date of Delivery.

Acceptance and Delivery will be complete once the signed packing slip is provided to the Vendor.

Inspection and acceptance will be performed at the place of installation –

The National Institutes of Health, NIDDK, Bldg. 8, Room B1A23, 9000 Rockville Pike, Bethesda, Maryland 20892.

For services, invoices will be approved by the Project officer and or COR according to payment terms in the resultant purchase order.

(vi) This is a competitive requirement being pursued through the authority granted in FAR 52.211-6, Brand Name or Equal. This is a requirement for a REVVITY HEALTH SCIENCES INC for a MLD Victor Nivo Alpha Instrument.

(vii)

(viii) The provision at FAR clause 52.212-1, Instructions to Offerors – Commercial Items, applies to this acquisition.

(ix) The provision at FAR clause 52.212-2, Evaluation – Commercial Items, is applicable.

Award will be made to the contractor providing the most advantageous quote to the Government. Technical factors and price considered with technical factors outweighing price.

Specifically, the following technical factors will be evaluated:

i. The vendor will be evaluated on their quoted product meeting the specifications under section 4.0 SALIENT / REQUIRED FEATURES AND SPECIFICATIONS.

ii. The Offeror should note that the evaluation criteria listed in order of importance are:

A. Technical – The services proposed by the vendor meets the requirements in the SOW

B. Cost/Price

The technical factors are as follows:

The evaluation will be based on the demonstrated capabilities of the prospective Offeror in relation to the needs of the project as set forth in the Statement of Work. The merits of the proposal will be evaluated carefully and will be deemed Acceptable or Unacceptable. The proposal must document the feasibility of successful implementation of the requirements of the Statement of Work. The Offeror must submit information sufficient to evaluate the proposal based on the detailed factors listed in section 4.0 SALIENT / REQUIRED FEATURES AND

SPECIFICATIONS.

Evaluation Criteria Acceptable Unacceptable

Technical The services proposed by the vendor meet the requirements in the SOW

Summary Overall Rating (Overall Risk)

Cost/Price Offerors will be evaluated based upon cost/price completeness and accuracy to determine the validity of the price, realism, reasonableness, and risk.

Technical Evaluation Rating Definitions

(x) FAR clause 52.212-3, Offeror Representations and Certifications – Commercial Items, is

Rating Definition Acceptable Proposal meets requirements and indicates an adequate approach and understanding of the requirements, and risk of unsuccessful performance is no worse than moderate.

Unacceptable Proposal does not meet requirements of the solicitation, and thus, contains one or more deficiencies, and/or risk of unsuccessful performance is unacceptable.

applicable. An offeror shall complete only paragraphs (b) of this provision if the offeror has completed the annual representations and certificates electronically via http://www.acquisition.gov If an offeror has not completed the annual representations and certifications electronically at the System for Award Management (SAM) website, the offeror shall complete only paragraphs (c) through (p) of this provision.

(x) FAR clause at 52.212-4, Contract Terms and Conditions – Commercial Items, applies to this acquisition.

(xi) FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders – Commercial Items, applies to this acquisition. Including the following clauses and Prohibitions:

i. 52.203-6, Restrictions on Subcontractor Sales to the Government

ii. 52.203-13, Contractor Code of Business Ethics and Conduct

iii. 52.204-10, Reporting Executive Compensation and First-Tier

Subcontract Awards

iv. 52.204-27, Prohibition on a ByteDance Covered Application

v. 52.209-6, Protecting the Government’s Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment

vi. 52.209-9, Updates of Publicly Available Information Regarding

Responsibility

vii. Matters

viii. FAR 52.211-6, Brand Name or Equal

ix. 52.219-4, Notice of Price Evaluation Preference for HUBZone Small

Business Concerns

x. 52.219-8, Utilization of Small Business Concerns

xi. 52.219-28, Post Award Small Business Program Representation

xii. 52.222-19, Child Labor—Cooperation with Authorities and Remedies

xiii. 52.222-21, Prohibition of Segregated Facilities

xiv. 52.222-26, Equal Opportunity

xv. 52.222-35, Equal Opportunity for Veterans

xvi. 52.222-36, Equal Opportunity for Workers with Disabilities

xvii. 52.222-37, Employment Reports on Veterans

xviii. 52.222-50 Combating Trafficking in Persons

xix. 52.223-18, Encouraging Contractor Policies to Ban Text Messaging while Driving

xx. 52.225-1, Buy American- Supplies

xxi. 52.225-13, Restrictions on Certain Foreign Purchases

Additional Clauses:

i. 52.232-29, Terms for Financing of Purchases of Commercial Items

ii. 52.232-33, Payment by Electronic Funds Transfer— System for Award

Management

iii. 52.232-39, Unenforceability of Unauthorized Obligations

(xii) Additional Contract Requirements:

The information submitted must be in and outline format that addresses each of the elements of the project requirement and in the capability statement /information sought paragraphs stated herein. A cover page and an executive summary may be included but is not required.

http://www.acquisition.gov/

One (1) copy of the response is required and must be in Microsoft Word or Adobe

PDF format using 11- point or 12-point font, 8-1/2" x 11" paper size, with 1" top, bottom, left and right margins, and with single or double spacing. The response is limited to ten (10) page limit. The 10-page limit does not include the cover page, executive summary, or references, if requested.

Vendor/Contractor Must be able to accept payments via IPP (Invoice Processing

Platform) The contractor may submit a request for an exception. See below for IPP, IPP helpdesk information and applicable Health and Human Services addendum clause.

INVOICING PROCESSING PLATFORM (IPP) In compliance with the Office of

Management and Budget (OMB) M-15-19 memorandum "Improving Government Efficiency and Saving Taxpayer Dollars through Electronic Invoicing" directing Federal agencies to adopt electronic invoicing as the primary means to disburse payment to vendors. Invoices submitted under any award resulting from this solicitation will be required to utilize the Invoice Processing Platform (IPP) in accordance with HHSAR 352.232-71, Electronic Submission and Processing of Payment Requests" IPP is a secure, web-based electronic invoicing system provided by the U.S. Department of the Treasury's Bureau of the Fiscal Service, in partnership with the Federal Reserve Bank of St. Louis (FRSTL). Respondents to this solicitation are encouraged to register an account with IPP if they have not already done so. If your organization is already registered to use IPP, you will not be required to re-register however, we encourage you make sure your organization and designated IPP user accounts are valid and up to date. The IPP website address is:

https://www.ipp.gov If you require assistance registering or IPP account access, please contact the IPP Helpdesk at (866) 973-3131 (M-F 8AM to 6PM ET), or IPPCustomerSupport@fiscal.treasury.gov Note: Should an Offeror feel that use of the IPP would be unduly burdensome, the response to this solicitation should include an explanation of this position for a determination by the contracting officer.

HHSAR 352.232-71 Electronic Submission of Invoice Payment Requests (Feb 2022) will apply when this requirement is solicited and awarded. As stated: (a) Definitions.

As used in this clause, Payment request means a bill, voucher, invoice, or request for contract financing payment with associated supporting documentation. The payment request must comply with the requirements identified in FAR 32.905(b), "Content of Invoices" and the applicable Payment clause included in this contract. (b) Except as provided in paragraph (c) of this clause, the Contractor shall submit payment requests electronically using the Department of Treasury Invoice Processing Platform (IPP) or successor system. Information regarding IPP, including IPP Customer Support contact information, is available at www.ipp.gov or any successor site. (c) The Contractor may submit payment requests using other than IPP only when the Contracting Officer authorizes alternate procedures in writing in accordance with HHS procedures. (d) If alternate payment procedures are authorized, the Contractor shall include a copy of the Contracting Officer's written authorization with each payment request. (END OF CLAUSE)

(xiii) The Defense Priorities and Allocations System (DPAS) and assigned rating are not applicable.

(xiv) Offers shall be submitted via email to amber.harris@nih.gov and must reference mailto:amber.harris@nih.gov

75N94024Q00154 in the subject line.

(18) Place of Contract Performance:

National Institute of Health, NIDDK 8 Center Drive Bethesda MD 20892

(19) Set-aside Status: This requirement is not set aside for small business.